Showing results (1231-1240 of 1,407) with videos related to
Sort By:
Pageof 141
Pharmacology Research & Perspectives|November 24, 2020
Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivityStacey Tannenbaum, Martin den Adel, Walter Krauwinkel, et al.Pharmacology Research & Perspectives|November 26, 2020
Pan-cancer population pharmacokinetics and exposure-safety and -efficacy analyses of atezolizumab in patients with high tumor mutational burdenColby S Shemesh, Phyllis Chan, Fatema A Legrand, et al.Pharmacology Research & Perspectives|February 23, 2018
Reduced alcohol-seeking in male offspring of sires exposed to alcohol self-administration followed by punishment-imposed abstinenceErin J Campbell, Jeremy P M Flanagan, Nathan J Marchant, et al.Pharmacology Research & Perspectives|January 2, 2020
The five dimensions of receptor pharmacology exemplified by melatonin receptors: An opinionJean A Boutin, Céline LegrosPharmacology Research & Perspectives|January 29, 2020
Assessment of contribution of BCRP to intestinal absorption of various drugs using portal-systemic blood concentration difference model in miceIichiro Kawahara, Satoyo Nishikawa, Akira Yamamoto, et al.Pharmacology Research & Perspectives|September 2, 2020
Medication-related problems and adverse drug reactions in Ethiopia: A systematic reviewBelayneh Kefale, Amsalu Degu, Gobezie T TegegnePharmacology Research & Perspectives|September 4, 2020
Diabetes medication regimens and patient clinical characteristics in the national patient-centered clinical research network, PCORnetKatherine N Bachmann, Christianne L Roumie, Andrew D Wiese, et al.Pharmacology Research & Perspectives|September 5, 2020
Real-time fluorometric evaluation of hepatoblast proliferation in vivo and in vitro using the expression of CYP3A7 coding for human fetus-specific P450Shota Okuyama, Fumihiko Kawamura, Musashi Kubiura, et al.Pharmacology Research & Perspectives|November 10, 2020
Regulatory post-market drug safety advisories on cardiac harm: A comparison of four national regulatory agenciesAshleigh Hooimeyer, Alice Bhasale, Lucy Perry, et al.Pharmacology Research & Perspectives|September 18, 2020
Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6Jan de Jong, Anna Mitselos, Wojciech Jurczak, et al.Pageof 141